Omega-6 fatty acid promotes growth of aggressive type of breast cancer

Linoleic acid enhances the growth of the hard-to-treat “triple negative” breast cancer subtype.

Pregnancy may reduce long COVID risk

Pregnancy may offer some protection from developing long COVID, found a new study led by Weill Cornell Medicine, University of Rochester Medical Center, University of Utah Health and Louisiana Public Health Institute.

AI meets oncology: New model personalizes bladder cancer treatment

Researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.

Cost of living is top issue for Empire State Poll respondents

Nearly 70% of New York state residents see the cost of living as the most important issue facing their households, according to the Empire State Poll, conducted in August 2024 by the ILR School’s Center for Applied Research on Work.

Weill Family Foundation’s $50M gift establishes Weill Cancer Hub East

Four leading research institutions, including Weill Cornell Medicine, have united under the Weill Cancer Hub East, an innovative, collaborative partnership that aims to transform cancer treatment.

Medical students use AI to practice communication skills

At Weill Cornell Medical College, students have a new tool for polishing their bedside manner and making a diagnosis: an artificial intelligence-powered virtual patient that simulates the doctor-patient interaction.

Medical students celebrate their future with Match Day successes

The Class of 2025 learned on March 21 where they will be doing their internship and residency training – setting the stage for the next several years of their medical careers and lives.

How CEO political activism can hurt (or help) business

Cornell Tech researchers illuminate circumstances under which it is more or less beneficial for CEOs to talk about politics.

Exploring vaccine to block maternal CMV transmission

A study out of Weill Cornell Medicine and Oregon Health & Science University provides critical insight for the development of a vaccine that can more effectively block the spread of cytomegalovirus across the placenta to babies before they're born.